Event
details
Profile
entry
Profiles
Appointments
 
  back
Bio 2008 - San Diego- CATALOGUE
Select the sectors for which you want to see a profile list
Choose 'All' for all profiles
OR 
select some specific sectors
(use the Ctrl-key if you want to select more than one item)


Reference #  Title
TO - 2 Patient reported outcomes for clinical trials
TO - 4 Cell therapy
TO - 5 Disposable high cell density bioreactor
TO - 8 ECG for clinical trials
TR - 26 FlandersBio Services
TO - 27 GENETIC ANALYSIS FOR CLINICAL RESEARCH - DNAVISION
TO - 29 KitoZyme : new vegetal biopolymers
TO - 30 A new enzyme with xylanase activity adapted for pulp and paper industrial processes and agrofood applications
TO - 32 BIA-ATR biosensors
TO - 33 Genetically modified Brucella cells and pharmaceutical composition containing these cells
TO - 34 Brachytherapy using a composite source
TO - 37 Radioactive nanoclusters for more efficient targeted radiotherapy
TR - 40 Invest in Wallonia
TO - 59 Peptisyntha
TO - 64 Chemoinformatics
TO - 65 FMD - I, a non-invasive cardiovascular risk assessment software
TO - 66 Highspeed x-Rays Digitizer
TO - 67 AIR Biotech
TO - 68 Cleaning solutions for laboratories and medical fields
TO - 69 Combining enzyme-antibody conjugates and antibiotics as medium additive for the selective growth of pathogenic bacteria in food analysis and medical diagnostics
TO - 70 Peroxisome-associated polypeptide (peroxiredoxin 5), nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders
TO - 71 Use of compound or pharmaceutical composition for the prevention and/or the treatment of ischemic heart and peripheral vascular diseases, tumour development and for wound healing
TO - 72 Methods and agents for the treatment of cancer
TO - 73 Positional cloning of the gene (VMGLOM) and its mutations causing dysmorphogenesis of blood vessels, venous malformations with glomus cells (glomangiomas)
TO - 74 Method for the determination and the classification of rheumatic conditions
TO - 75 Methods for preparing perfluorinated [18F]-radiolabelled nitroimidazole derivatives for cellular hypoxia detection
TO - 76 Method, device and kit for determining conditions related to a dysfunction of the renal proximal tubule
TO - 77 Method and kit for determining antigen content in a sample using double immunohistochemical detection
TO - 78 Use of agonists and antagonists of beta-adrenoceptors for treating arterial diseases
TO - 79 Medical use of ras antagonists for the treatment of capillary malformation
TO - 80 Assay for detecting and identifying micro-organisms
TO - 82 Glycosylated triketide delta lactones
TO - 83 Method for treating neuropathic pain and pharmaceutical preparation therefor
TO - 84 Healthy food expertise for Turkish, Congolese, Moroccan and related ethnic groups
TO - 85 LSTA - Laboratory of Sensory Technology and Analysis
TO - 86 InduTec, the Technology Transfer Centre of the 4 Engineering Institutes of Brussels
TO - 87 SYNERGIES WITH BIO INCUBATORS
TO - 88 Food products
TO - 89 Delphi Genetics
TO - 90 Biometry Experts
TO - 91 BioXpr : an innovative company providing expert services and products in bioinformatics
TR - 93 UCB - the next-generation biopharma leader
TO - 94 Development and surface engineering of standardised activated carbon
TO - 95 Development and optimisation of hydrogenation catalysts/mild oxidation test reactions
TO - 96 R&D expertise in supported noble & transition metals
TO - 97 GSK Biologicals
TO - 98 The Tremor Coherence Analyzer (TCA): an automatic portable medical device for pathological tremor study and analysis
TO - 99 New antiviral agents against clinically important HIV mutant strains
TO - 100 ULg - Several collaboration and licensing opportunities
TO - 101 Biometry Services for Clinical Studies
TO - 102 Henogen, Contract Biomanufacturing
TO - 103 Solid lipid particles as pharmaceutically acceptable fillers or carriers for inhalation
TO - 104 New, inducible/repressible AAV vectors for gene therapy
TO - 105 New perspectives in the treatment of trypanosome infections
TO - 106 Photoreactive Ru (II) complexes anchored on oligonucleotides for cancer therapy
TO - 107 Plant genes for the design of heavy metal tolerant crops useful in phytoremediation techniques
TO - 108 Immune monitoring in whole blood using real-time PCR
TO - 109 Characterisation and enhancement of the nutritional quality of beers and yeast products
TO - 110 Highly concentrated and stabilised microorganisms for environmental cleaning
TO - 111 Laboratory animal services
TO - 112 Bifunctional Hybrid Proteins
TO - 113 Manufacturing of peptides by solid and solution phase techniques
TO - 114 ePRO for clinical trails
TR - 115 Oral Peptide Drug Delivery
TO - 118 Fermentation technology for bioethanol production
TO - 120 Market Access for Pharmaceuticals and Medical Devices
TO - 121 Chronic Wound Care - Devices and Other Technology
TR - 122 Clinical Research in Chile
TO - 123 Strategic decision models
TO - 124 Clinical Trials in Russia, Ukraine and Eastern Europe - various therapeutic areas
TO - 125 We provide the complete range of legal services to Biotechnology companies

We take no responsibility for the information provided by the participating companies.